(S (NP (NP (JJ Clinical) (NNS trials)) (PP (IN in) (NP (DT the) (JJ medical) (NN domain)))) (VP (VBP are) (VP (VBN constrained) (PP (IN by) (NP (NNS budgets))))) (. .))
(S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NNS patients))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN recruited))))))) (VP (VBZ is) (ADVP (RB therefore)) (ADJP (JJ limited))) (. .))
(S (SBAR (WHADVP (WRB When)) (S (NP (DT a) (JJ patient) (NN population)) (VP (VBZ is) (ADJP (JJ heterogeneous))))) (, ,) (NP (DT this)) (VP (VBZ creates) (NP (NP (NNS difficulties)) (PP (PP (IN in) (S (VP (VBG learning) (NP (NP (NN subgroup) (JJ specific) (NNS responses)) (PP (TO to) (NP (DT a) (JJ particular) (NN drug))))))) (CC and) (PP (ADVP (RB especially)) (IN for) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS dosages)))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ patient) (NN recruitment)) (VP (MD can) (VP (VB be) (ADJP (JJ difficult)) (PP (IN by) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (JJ clinical) (NNS trials)) (VP (VBP do) (RB not) (VP (VB aim) (S (VP (TO to) (VP (VB provide) (NP (DT a) (NN benefit)) (PP (TO to) (NP (NP (DT any) (VBN given) (NN patient)) (PP (IN in) (NP (DT the) (NN trial)))))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (NNP C3T-Budget)) (, ,) (NP (NP (DT a) (ADJP (JJ contextual) (JJ constrained)) (JJ clinical) (NN trial) (NN algorithm)) (PP (IN for) (NP (NP (NN dose-finding)) (PP (IN under) (NP (DT both) (NN budget) (CC and) (NN safety) (NNS constraints)))))))) (. .))
(S (NP (DT The) (NN algorithm)) (VP (VBZ aims) (S (VP (TO to) (VP (VB maximize) (NP (NN drug) (NN efficacy)) (PP (IN within) (NP (DT the) (JJ clinical) (NN trial))) (SBAR (IN while) (S (ADVP (RB also)) (VP (VBG learning) (PP (IN about) (NP (NP (DT the) (NN drug)) (VP (VBG being) (VP (VBN tested)))))))))))) (. .))
(S (NP (JJ C3T-Budget)) (VP (NNS recruits) (NP (NNS patients)) (PP (IN with) (NP (NP (NN consideration)) (PP (IN of) (NP (NP (DT the) (VBG remaining) (NN budget)) (, ,) (NP (DT the) (VBG remaining) (NN time)) (, ,) (CC and) (NP (NP (DT the) (NNS characteristics)) (PP (IN of) (NP (DT each) (NN group))) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN population) (NN distribution)) (, ,) (NP (VBN estimated) (VBN expected) (NN efficacy)) (, ,) (CC and) (NP (NN estimation) (NN credibility)))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN algorithm)) (VP (VBZ aims) (S (VP (TO to) (VP (VB avoid) (NP (JJ unsafe) (NNS dosages)))))) (. .))
(S (NP (DT These) (NNS characteristics)) (VP (VBP are) (VP (ADVP (RB further)) (VBN illustrated) (PP (IN in) (NP (NP (DT a) (JJ simulated) (JJ clinical) (NN trial) (NN study)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ corroborates) (NP (DT the) (JJ theoretical) (NN analysis))) (CC and) (VP (VBZ demonstrates) (NP (NP (DT an) (JJ efficient) (NN budget) (NN usage)) (CONJP (RB as) (RB well) (IN as)) (NP (DT a) (JJ balanced) (JJ learning-treatment) (NN trade-off))))))))))) (. .))
